"A causal link with the vaccine is not proven but is possible, and further analysis is continuing," it added. Cavaleri told the Italian newspaper on Tuesday that the assessment process was "far from over." The EMA is expected to provide a new evaluation on the use of the AstraZeneca vaccine soon, perhaps by late Wednesday, the European Union's (EU) Health Commissioner Stella Kyriakides said on Twitter on Tuesday. Meanwhile, the Italian Medicines Agency (AIFA) and the Health Ministry were also due to discuss the issue late on Tuesday, although the AIFA would reportedly not issue any new rule on the AstraZeneca vaccine's use pending the EMA's decision.